Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of the Clinical Practice in Patients With Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma in Greece

NCT03266757 is registered in ClinicalTrials.gov with Hellenic Society of Medical Oncology as lead sponsor.

NCT NCT03266757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03266757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of the Clinical Practice in Patients With Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma in Greece
Lead sponsor
Hellenic Society of Medical Oncology
Phase
Observational
Overall status
Completed
Start date
February 11, 2016
Completion date
February 11, 2018
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma